My­lan CEO to tes­tify in hear­ing on EpiPen price in­creases

Daily Local News (West Chester, PA) - - BUSINESS - By Mary Clare Jalonick

WASH­ING­TON >> The head of My­lan will face law­mak­ers’ ques­tions at a hear­ing next week on steep price hikes for the com­pany’s life-sav­ing EpiPen in­jec­tor de­vice.

My­lan CEO Heather Bresch and of­fi­cials from the Food and Drug Ad­min­is­tra­tion will tes­tify be­fore the House Over­sight and Govern­ment Re­form Com­mit­tee.

The Repub­li­can chair­man of the com­mit­tee and the panel’s top Demo­crat said in a state­ment that there is “jus­ti­fied out­rage” from fam­i­lies and schools strug­gling to pay for the emer­gency al­lergy shots. The price has grown to $608 for a two-pack, up more than 500 per­cent since 2007.

Reps. Ja­son Chaf­fetz of Utah and Eli­jah Cum­mings of Mary­land said they will also ex­am­ine ways to en­cour­age greater com­pe­ti­tion in the EpiPen mar­ket.

Bresch is the daugh­ter of Demo­cratic Sen. Joe Manchin of West Vir­ginia.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.